SAN DIEGO and PERTH, Australia -- PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced residency at Johnson & Johnson Innovation, JLABS at San Diego (JLABS @ SAN DIEGO) after a successful application and selection process. This new […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
S&P Global Ratings lifted BRIDGE Housing Corp.'s issuer credit rating and the...
ByThe RegistryOctober 9, 2026Three years after buying the aging Westfield Mission Valley from Unibail-Rodamco-Westfield, Lowe...
ByThe RegistryOctober 8, 2026A trio of century-old buildings at Broadway and Fourth and Fifth avenues...
ByThe RegistryOctober 8, 2026San Diego's retail market absorbed a modest vacancy uptick through mid-2026, but...
ByThe RegistryOctober 7, 2026Error: Contact form not found.